Dan Balcauski speaks with Mike Klein, CEO of Genomenon, a genomics intelligence company that combines AI, data, and real-world evidence to create a comprehensive knowledge base for precision therapeutics. Mike discusses his journey in scaling Genomenon, the challenges of selling to scientifically-minded customers, and the strategic shift to a freemium model that led to significant adoption. He highlights the complexities of transitioning from a small to a large team, the importance of delegation, and leveraging board relationships for company growth. Mike also shares insights on maintaining company culture, learning continually, and the invaluable lessons from his mentor. 

01:19 Meet Mike Klein, CEO of Genomenon
03:48 Navigating the Genomics Market
10:19 Freemium Model Success
18:20 Delegation and Leadership Insights
26:22 Board Relationships and Governance

Guest Links

Genomenon.com